These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 21849905

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM, Singh P, Shepherd CJ, Puthiryackal J.
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of clozapine use in delaying hospitalization in routine clinical practice: a 2 year observational study.
    Nyakyoma K, Morriss R.
    Psychopharmacol Bull; 2010 Apr; 43(2):67-81. PubMed ID: 21052043
    [Abstract] [Full Text] [Related]

  • 4. Clozapine-withdrawal catatonia.
    Wadekar M, Syed S.
    Psychosomatics; 2010 Apr; 51(4):355-355.e2. PubMed ID: 20587767
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clozapine use in a forensic population in a New South Wales prison hospital.
    Martin A, O'Driscoll C, Samuels A.
    Aust N Z J Psychiatry; 2008 Feb; 42(2):141-6. PubMed ID: 18197509
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clozapine for resistant schizophrenia and characteristics of those responding].
    Talmon Y, Guy N, Wittenberg N.
    Harefuah; 1995 Dec 01; 129(11):451-4, 536. PubMed ID: 8846949
    [Abstract] [Full Text] [Related]

  • 11. New vs. old antipsychotics: the Texas experience.
    Reid WH.
    J Clin Psychiatry; 1999 Dec 01; 60 Suppl 1():23-5; discussion 28-30. PubMed ID: 10037167
    [Abstract] [Full Text] [Related]

  • 12. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ.
    Clin Ther; 2007 Jan 01; 29(1):183-95. PubMed ID: 17379060
    [Abstract] [Full Text] [Related]

  • 13. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
    Volavka J.
    J Clin Psychiatry; 1999 Jan 01; 60 Suppl 12():43-6. PubMed ID: 10372611
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study.
    Nielsen J, Nielsen RE, Correll CU.
    J Clin Psychopharmacol; 2012 Oct 01; 32(5):678-83. PubMed ID: 22926603
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical use of clozapine in a major urban setting: one year experience.
    Chow EW, Collins EJ, Nuttall SE, Bassett AS.
    J Psychiatry Neurosci; 1995 Mar 01; 20(2):133-40. PubMed ID: 7703222
    [Abstract] [Full Text] [Related]

  • 20. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J, Marcus SC, West J, Countis L, Hall R, Regier DA, Olfson M.
    J Nerv Ment Dis; 2006 Jun 01; 194(6):454-7. PubMed ID: 16772865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.